Kura Oncology (KURA Quick QuoteKURA - Free Report) was a big mover last session, as the company saw its shares rise almost 7% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $5.95 to $6.65 in the past one-month time frame.

In the last 30 days, the company has seen no estimate revision and the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.        

Kura Oncology currently has a Zacks Rank #3 (Hold).

Kura Oncology, Inc. Price

 

Kura Oncology, Inc. Price | Kura Oncology, Inc. Quote

A better-ranked Medical - Biomedical and Genetics stock is Cytokinetics, Incorporated (CYTK Quick QuoteCYTK - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is KURA going up? Or down? Predict to see what others think: Up or Down

Just Released – Driverless Cars: Your Roadmap to Mega-Profits Today

In this latest Special Report, Zacks’ Aggressive Growth Strategist Brian Bolan explores a full-blown technological breakthrough in the making – autonomous cars. He also spotlights 8 stocks with tremendous gain potential to feed off this phenomenon. Click to see the stocks right now >>